Clinical studies recruiting near Incheon

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · Catholic Kwandong University International St. Mary's Hospit · Eisai Korea Inc. · NCT06246123 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Gachon University Gil Medical Center · Pfizer · NCT07073820 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Gachon University Gil Medical Center · Amgen · NCT07037433 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Gachon University Gil Medical Center · Regeneron Pharmaceuticals · NCT06091865 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no O
Phase 3 · Gachon University Gil Medical Center · Actelion · NCT05179876 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · The Catholic University of Korea, Incheon St. Mary's Hospita · Boehringer Ingelheim · NCT06531824 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NA · The Catholic University of Korea, Incheon ST. Mary's Hospita · Yonsei University · NCT05490433 South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
NA · Inha University Hospital · Seong Hye Choi, MD · NCT06891573 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · Research Site · AstraZeneca · NCT06535607 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · Inha University Hospital · Taiho Oncology, Inc. · NCT05967689 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Gachon University Gil Medical Center · Daiichi Sankyo · NCT06731478 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · Gachon University Gil Medical Center /ID# 279592 · AbbVie · NCT07525206 Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3 · Incheon St.Mary's Hospital/The Catholic University · National Cancer Center, Korea · NCT04214990 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Inha University Hospital · Ipsen · NCT06016842 Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Phase 2 · Gachon University Gil Medical Center · Regeneron Pharmaceuticals · NCT06787612 Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Phase 2 · The Catholic University of Korea Incheon St. Mary's Hospital · Aptabio Therapeutics, Inc. · NCT06962098 Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal
NA · Inha University Hospital · Deepsonbio · NCT07239310 Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien
NA · Gachon University Gil Medical Center · Samsung Medical Center · NCT07009418 AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
Phase N/A · Inha University Hospital · Inha University Hospital · NCT07347691 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENT
Phase 4 · Catholic Kwandong University International St. Mary's Hospit · Seoul National University Hospital · NCT05845489 A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblas
Phase 1/Phase 2 · The Catholic University of Korea, Incheon St. Mary's Hospita · Rznomics, Inc. · NCT06102525 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · Gachon University Gil Medical Center · Takeda · NCT05442567 CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Phase N/A · Research Site · AstraZeneca · NCT06927648 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374

Look up another city

Look up another condition